Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;80:969-982

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolfe, C. L.
Right arrow Articles by Brasch, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolfe, C. L.
Right arrow Articles by Brasch, R. C.

Circulation, Vol 80, 969-982, Copyright © 1989 by American Heart Association


ARTICLES

Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy

CL Wolfe, ME Moseley, MG Wikstrom, RE Sievers, MF Wendland, JW Dupon, WE Finkbeiner, MJ Lipton, WW Parmley and RC Brasch
Department of Internal Medicine (Cardiology), University of California, San Francisco 94143-0124.

To test the hypothesis that contrast-enhanced magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) can differentiate reversible from irreversible myocardial injury, these modalities were used to study ischemia and reperfusion in a rat model. The presence of ischemia and reperfusion were confirmed with radiolabeled microspheres (n = 6). Groups of animals were subjected to either 16 (n = 17), 30 (n = 14), 60 (n = 11), or 90 (n = 14) minutes of left coronary artery (LCA) occlusion and 60 minutes reperfusion. After albumin-gadolinium (Gd)-DTPA injection, contrast-enhanced, T1-weighted, spin-echo proton images were acquired at baseline and every 16 minutes during LCA occlusion and reperfusion. In separate experiments, 31phosphorus (31P) spectra were acquired at similar time points during ischemia and reperfusion. After 16 minutes occlusion, normally perfused myocardium enhanced significantly compared with ischemic myocardium on MRI (104 +/- 7.9% vs. 61 +/- 11.0%, p less than 0.05, n = 5, mean +/- SEM, % of baseline value). MRS showed reduced phosphocreatine (PCr) and adenosine triphosphate (ATP) (58.8 +/- 2.4%, p less than or equal to 0.01; 81.4 +/- 2.4, p less than or equal to 0.01, n = 12). After 16 or 30 minutes ischemia, reflow resulted in uniform MRI signal intensity of the ischemic zone compared with normal myocardium (93.5 +/- 11.3 vs. 80.9 +/- 7.0, p = NS, n = 11, % of baseline value at 30 minutes reperfusion) and PCr recovery on MRS (94.3 +/- 4.0%, p = NS, n = 20, % baseline value at 30 minutes reflow). After 60 and 90 minutes ischemia, reflow resulted in marked enhancement of reperfused compared with normal myocardium on MRI (254.0 +/- 30.0 vs. 78.3 +/- 9.2, p less than or equal to 0.01, n = 10) and no recovery of PCr on MRS (64.1 +/- 3.0, p = NS, n = 14). Triphenyltetrazolium chloride (TTC) staining revealed transmural myocardial infarction (MI) in all hearts subjected to 60 or 90 minutes ischemia and reflow, and small nontransmural MIs in only 2/11 hearts subjected to 16 or 30 minutes ischemia and reperfusion. Thus, 1) MRI with albumin-Gd-DTPA is useful for identifying myocardial ischemia by enhancing the contrast between normally perfused and ischemic myocardia; 2) MRI with albumin-Gd-DTPA is useful for identifying reperfusion after myocardial ischemia; and 3) after reperfusion, reversible can be distinguished from irreversible myocardial injury by characteristic findings on MRI and MRS.


This article has been cited by other articles:


Home page
Stem CellsHome page
R. J. Lee, Q. Fang, P. A. Davol, Y. Gu, R. E. Sievers, R. C. Grabert, J. M. Gall, E. Tsang, M. S. Yee, H. Fok, et al.
Antibody Targeting of Stem Cells to Infarcted Myocardium
Stem Cells, March 1, 2007; 25(3): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Saeed, O. Weber, R. Lee, L. Do, A. Martin, D. Saloner, P. Ursell, P. Robert, C. Corot, and C. B. Higgins
Discrimination of Myocardial Acute and Chronic (Scar) Infarctions on Delayed Contrast Enhanced Magnetic Resonance Imaging With Intravascular Magnetic Resonance Contrast Media
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1961 - 1968.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. J. Crozier, X. Zhang, J. Wang, J. Cheung, S. R. Kimball, and L. S. Jefferson
Activation of signaling pathways and regulatory mechanisms of mRNA translation following myocardial ischemia-reperfusion
J Appl Physiol, August 1, 2006; 101(2): 576 - 582.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. L. Christman, A. J. Vardanian, Q. Fang, R. E. Sievers, H. H. Fok, and R. J. Lee
Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 654 - 660.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ramani, R. M. Judd, T. A. Holly, T. B. Parrish, V. H. Rigolin, M. A. Parker, C. Callahan, S. W. Fitzgerald, R. O. Bonow, and F. J. Klocke
Contrast Magnetic Resonance Imaging in the Assessment of Myocardial Viability in Patients With Stable Coronary Artery Disease and Left Ventricular Dysfunction
Circulation, December 15, 1998; 98(24): 2687 - 2694.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Bremerich, M. F. Wendland, H.a. Arheden, R. Wyttenbach, D. W. Gao, J. P. Huberty, M. W. Dae, C. B. Higgins, and M. Saeed
Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging
J. Am. Coll. Cardiol., September 1, 1998; 32(3): 787 - 793.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Kim, E.-L. Chen, J. A.C. Lima, and R. M. Judd
Myocardial Gd-DTPA Kinetics Determine MRI Contrast Enhancement and Reflect the Extent and Severity of Myocardial Injury After Acute Reperfused Infarction
Circulation, December 15, 1996; 94(12): 3318 - 3326.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Simor, W.-J. Chu, L. Johnson, A. Safranko, M. Doyle, G. M. Pohost, and G. A. Elgavish
In Vivo MRI Visualization of Acute Myocardial Ischemia and Reperfusion in Ferrets by the Persistent Action of the Contrast Agent Gd(BME-DTTA)
Circulation, December 15, 1995; 92(12): 3549 - 3559.
[Abstract] [Full Text]


Home page
CirculationHome page
E. E. van der Wall, H. W. Vliegen, A. de Roos, and A. V.G. Bruschke
Magnetic Resonance Imaging in Coronary Artery Disease
Circulation, November 1, 1995; 92(9): 2723 - 2739.
[Abstract] [Full Text]


Home page
CirculationHome page
R. M. Judd, C. H. Lugo-Olivieri, M. Arai, T. Kondo, P. Croisille, J. A.C. Lima, V. Mohan, L. C. Becker, and E. A. Zerhouni
Physiological Basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts
Circulation, October 1, 1995; 92(7): 1902 - 1910.
[Abstract] [Full Text]


Home page
CirculationHome page
J. A. C. Lima, R. M. Judd, A. Bazille, S. P. Schulman, E. Atalar, and E. A. Zerhouni
Regional Heterogeneity of Human Myocardial Infarcts Demonstrated by Contrast-Enhanced MRI : Potential Mechanisms
Circulation, September 1, 1995; 92(5): 1117 - 1125.
[Abstract] [Full Text]